TheraSelect GmbH covers the German production locations in Marburg and Pfullingen. Both locations have many years’ experience and expertise in the production of infusion solutions and injected products in various formats and primary packaging (glass/plastics). Marburg produces the volume substitute Haemaccel ®, which was acquired by Aventis Pharma Germany in 2004 and is already licensed in more than 50 countries.